A Randomized, Double-Blind, Vehicle-Controlled Study to Evaluate the Safety and Efficacy of BTX 1503 in Patients With Moderate to Severe Acne Vulgaris
Phase of Trial: Phase II
Latest Information Update: 25 Jan 2019
At a glance
- Drugs Cannabidiol (Primary)
- Indications Acne vulgaris
- Focus Therapeutic Use
- Sponsors Botanix Pharmaceuticals
- 23 Jul 2018 Status changed from not yet recruiting to recruiting, as reported in the Botanix Pharmaceuticals media release.
- 23 Jul 2018 According to a Botanix Pharmaceuticals media release, the company has completed the Investigator's Meeting for this trial.
- 28 Jun 2018 New trial record